Skip to content
healthcare.dev

PROLEUKIN

NDC 73776-022, aldesleukin, injection, powder, lyophilized, for solution, from Iovance Biotherapeutics, Inc.

Product NDC
73776-022
Status
Listed
Labeler
Iovance Biotherapeutics, Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103293
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73776-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALDESLEUKIN1.1 mg/mL

Pharmacologic classes

Increased Lymphocyte Activation [PE]; Increased Lymphocyte Cell Production [PE]; Interleukin-2 [CS]; Lymphocyte Growth Factor [EPC]

Package NDCNDC-11Package
73776-022-01737760022011 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f3c516ad-d405-4fbe-af6a-962080dbfa7d

Use it

Look up 73776-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73776-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73776-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.